Skip to content
Isoniazid/Rifapentine (3HP) Access Roadmap and Patent Landscape report cover

Isoniazid/Rifapentine (3HP) Access Roadmap and Patent Landscape

  • Dorrit Walsh

Our publication, Isoniazid/Rifapentine (3HP) Access Roadmap and Patent Landscape, provides a landscape of patent applications filed by the French pharmaceutical company Sanofi on combinations of two essential medicines used to prevent tuberculosis (TB): isoniazid and rifapentine.

Read more

An Activist’s Guide to the LAM Test

  • Chad Cipiti

Tuberculosis (TB) is the number one killer of people living with HIV/AIDS, causing one in three of all AIDS-related deaths. People living with HIV are at increased risk of developing TB, and of dying from it—especially when they have advanced…

Read more
Image of page one: TAG Update 2019

2019 TAG Update

  • Dorrit Walsh

TAG’s work in 2019 demonstrated our leadership towards an end to HIV, hepatitis C, and tuberculosis through hard-hitting, science-based activism. Excerpts of the media coverage we received walk you through a remarkable year of TAG’s work.

Read more
Cover of Tuberculosis Research Funding Trends 2005-2018

2019 Report on TB Research Funding Trends

  • Dorrit Walsh

TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2018 and analyzes trends in funding since 2005.

Read more

Treatment Action Group Applauds Indian TB Activists in Opposing Patents for Critical TB Prevention Drugs

  • Dorrit Walsh

Treatment Action Group (TAG) applauds the legal actions undertaken by our colleagues from the Delhi Network of Positive People (DNP+) and tuberculosis (TB) survivor and activist Ganesh Acharya of Mumbai, with support from the Third World Network (TWN), contesting two patent applications on combinations of two decades-old TB medicines filed in India by French pharmaceutical company Sanofi.

Read more
Full cover image of November 2019 TAGline - Vote your ConSCIENCE: Elevating Health Justic in the 2020 Elections

TAGline November 2019

  • Dorrit Walsh

Vote Your ConSCIENCE: Elevating Health Justice in the 2020 Elections. 2020 marks the eighth U.S. presidential election cycle since Treatment Action Group’s founding in 1992. A hallmark of our activism has been to prepare for each presidential and congressional election cycle strategically, to ensure that whoever is elected, and whoever controls the House and the Senate, is informed about the best scientifically grounded research and policy and research programs.

Read more

Letters to Include Four TB Drugs on WHO’s Model List of Essential Medicines

  • Chad Cipiti

To encourage more equitable access to new and repurposed TB drugs, TAG signed on to letters of support for the inclusion of rifapentine, bedaquiline, delamanid, and linezolid on the WHO's Model List of Essential Medicines. The 20th Expert Committee on the Selection and Use of Essential Medicines will review drug applications and public comments in April 2015.

Read more
Back To Top